Home » Topics » BioWorld Science

BioWorld Science
RSS

Cephalon awarded patents for IGF-1

Aug. 26, 1997

Protein Design Labs: Q2 1997 highlights

Aug. 26, 1997

CAT's anti-TGF-beta2 antibody approved for phase I/IIa trials

Aug. 26, 1997

FDA approves expansion of Sunrise Technologies' hyperopia study

Aug. 26, 1997

New aldosterone antagonists from Yamanouchi

Aug. 26, 1997

Pace launches Cardiologic system

Aug. 25, 1997

Ergo issued method-of-use patents for Ergoset

Aug. 25, 1997

HemoCleanse receives NIH grant to develop bioartificial liver

Aug. 25, 1997

Medtronic initiates U.S. clinical trials of beStent Rival

Aug. 25, 1997

FDA approves Watson's estazolam

Aug. 25, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 17, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Voyager’s gene therapy reduces tau levels in AD models
BioWorld Science
At the Alzheimer’s Association International Conference, researchers from Voyager Therapeutics Inc. presented preclinical efficacy data for VY-1706, a blood-brain...